Fludara and Supraventricular extrasystoles - a phase IV clinical study of FDA data

Summary:

Supraventricular extrasystoles is reported as a side effect among people who take Fludara (fludarabine phosphate), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Pentacarinat, and have Atrial fibrillation/flutter.

The phase IV clinical study analyzes which people have Supraventricular extrasystoles when taking Fludara. It is created by eHealthMe based on reports of 46,669 people who have side effects when taking Fludara from the FDA, and is updated regularly.

What is Fludara?

Fludara has active ingredients of fludarabine phosphate. eHealthMe is studying from 46,686 Fludara users. Check the latest studies of Fludara.

What is Supraventricular extrasystoles?

Supraventricular extrasystoles (premature electrical impulse in the heart, generated above the level of the ventricle) is found to be associated with 662 drugs and 732 conditions by eHealthMe. Check the latest studies of Supraventricular extrasystoles.



On Jul, 06, 2026

46,669 people reported to have side effects when taking Fludara.
Among them, 13 people (0.03%) have Supraventricular extrasystoles.

Could Fludara cause Supraventricular extrasystoles?

Among these 13 people:

How long have people been on Fludara when they have Supraventricular extrasystoles? *

  • < 1 month: 85.71 %
  • 1 - 6 months: 14.29 %
  • 6 - 12 months: 0.0 %
  • 1 - 2 years: 0.0 %
  • 2 - 5 years: 0.0 %
  • 5 - 10 years: 0.0 %
  • 10+ years: 0.0 %

What is the gender of people who have Supraventricular extrasystoles when taking Fludara? *

  • female: 53.85 %
  • male: 46.15 %

What is the age of people who have Supraventricular extrasystoles when taking Fludara? *

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 10 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 0.0 %
  • 50-59: 0.0 %
  • 60+: 90 %

What are other drugs people take besides Fludara? *

  1. Lopressor: 5 people, 38.46%
  2. Ibrutinib: 5 people, 38.46%
  3. Pentacarinat: 5 people, 38.46%
  4. Bactrim: 3 people, 23.08%
  5. Cyclophosphamide: 2 people, 15.38%
  6. Mitoxantrone: 2 people, 15.38%
  7. Cyclosporine: 2 people, 15.38%
  8. Cytarabine: 2 people, 15.38%
  9. Altace: 1 person, 7.69%
  10. Busulfan: 1 person, 7.69%

What are other side effects people have besides Supraventricular extrasystoles? *

  1. Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 7 people, 53.85%
  2. Heart Palpitations (feelings or sensations that your heart is pounding or racing): 5 people, 38.46%
  3. Dyspnea (difficult or laboured breathing): 5 people, 38.46%
  4. Diarrhea: 5 people, 38.46%
  5. Chest Pain: 5 people, 38.46%
  6. Dermatitis Allergic (inflammation of the skin due allergic reaction): 4 people, 30.77%
  7. Sepsis (a severe blood infection that can lead to organ failure and death): 3 people, 23.08%
  8. Fever: 3 people, 23.08%
  9. Thrombocytopenia (decrease of platelets in blood): 3 people, 23.08%
  10. Small For Dates Baby (an unborn baby is growing more slowly and is smaller than most babies are at the same age): 2 people, 15.38%

What are the existing conditions these people have? *

  1. High Blood Pressure: 5 people, 38.46%
  2. Dyslipidaemia (abnormal amount of lipids): 5 people, 38.46%
  3. Chronic Lymphocytic Leukaemia (cancer in which the bone marrow makes too many lymphocytes (a type of white blood cell)): 5 people, 38.46%
  4. Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 5 people, 38.46%
  5. Thrombosis (formation of a blood clot inside a blood vessel): 3 people, 23.08%
  6. Atrial Thrombosis (blood clot that develops in an artery): 2 people, 15.38%
  7. Waldenstrom's Macroglobulinaemia (cancer affects small lymphocytes (white blood cells)): 1 person, 7.69%
  8. Richter's Syndrome (hairy cell cancer changes in fast growing b cell cancer tumour): 1 person, 7.69%
  9. Non-Hodgkin's Lymphoma (malignant (cancer) cells form in the lymph system): 1 person, 7.69%
  10. Nerve Root Compression: 1 person, 7.69%

* Approximation only. Some reports may have incomplete information.

Do you take Fludara and have Supraventricular extrasystoles?

- Check whether Supraventricular extrasystoles is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, long term effects of, and alternative drugs to Fludara:

Supraventricular extrasystoles treatments and more:

How severe was Supraventricular extrasystoles and when was it recovered:

Expand to all the drugs that have ingredients of fludarabine phosphate:

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Fludara:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Supraventricular extrasystoles:

Browse all the conditions that are associated with Supraventricular extrasystoles:


How the study uses the data?

The study uses data from the FDA. It is based on fludarabine phosphate (the active ingredients of Fludara) and Fludara (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: